The 50-day moving average for ABEO moved below the 200-day moving average on October 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABEO as a result. In 78 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for ABEO turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 33 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ABEO entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABEO advanced for three days, in 209 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
ABEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.862) is normal, around the industry mean (3.498). P/E Ratio (-3.446) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (13.089) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. ABEO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where INTS advanced for three days, in 101 of 146 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for INTS just turned positive on November 11, 2026. Looking at past instances where INTS's MACD turned positive, the stock continued to rise in 18 of 32 cases over the following month. The odds of a continued upward trend are 56%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 25 of 26 cases where INTS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INTS as a result. In 55 of 58 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
INTS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for INTS entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.074) is normal, around the industry mean (3.498). P/E Ratio (-1.515) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. INTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ABEO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 52 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 93 | |
P/E GROWTH RATING 1..100 | 98 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ABEO | INTS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | N/A |
| Stochastic ODDS (%) | 1 day ago 82% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 56% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 90% |
| Advances ODDS (%) | 14 days ago 83% | 10 days ago 69% |
| Declines ODDS (%) | 1 day ago 84% | 6 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 85% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 75% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABEO’s FA Score shows that 1 FA rating(s) are green while INTS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABEO’s TA Score shows that 4 TA indicator(s) are bullish while INTS’s TA Score has 1 bullish TA indicator(s).
ABEO (@Biotechnology) experienced а -42.24% price change this week, while INTS (@Biotechnology) price change was -8.58% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
ABEO is expected to report earnings on Mar 24, 2027.
INTS is expected to report earnings on Mar 18, 2027.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ABEO has been closely correlated with ZURA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if ABEO jumps, then ZURA could also see price increases.
| Ticker / NAME | Correlation To ABEO | 1D Price Change % | ||
|---|---|---|---|---|
| ABEO | 100% | -6.31% | ||
| ZURA - ABEO | 68% Closely correlated | +1.78% | ||
| ACAD - ABEO | 57% Loosely correlated | +0.49% | ||
| TSHA - ABEO | 51% Loosely correlated | +0.12% | ||
| KROS - ABEO | 47% Loosely correlated | +2.25% | ||
| IMTX - ABEO | 47% Loosely correlated | +4.21% | ||
More | ||||
A.I.dvisor tells us that INTS and TNYA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and TNYA's prices will move in lockstep.
| Ticker / NAME | Correlation To INTS | 1D Price Change % | ||
|---|---|---|---|---|
| INTS | 100% | +6.15% | ||
| TNYA - INTS | 33% Poorly correlated | +0.16% | ||
| CRBP - INTS | 32% Poorly correlated | +1.78% | ||
| CHRS - INTS | 32% Poorly correlated | -9.11% | ||
| ACAD - INTS | 28% Poorly correlated | +0.49% | ||
| ABEO - INTS | 28% Poorly correlated | -6.31% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QQQY | 20.15 | 0.41 | +2.08% |
| Defiance Nasdaq 100 Weekly Distribution ETF (QQQY) | |||
| CPSA | 28.19 | 0.03 | +0.12% |
| Calamos S&P 500 Structured Alt Protection ETF August (CPSA) | |||
| UCC | 49.07 | -0.09 | -0.19% |
| ProShares Ultra Consumer Discretionary (UCC) | |||
| CEF | 38.17 | -0.27 | -0.70% |
| Sprott Physical Gold and Silver Trust | |||
| LGOV | 20.21 | -0.15 | -0.74% |
| First Trust Long Duration Opportunities ETF (LGOV) | |||